Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

• Главные авторы: María José Méndez-Vidal (Автор), Áurea Molina (Автор), Urbano Anido (Автор), Isabel Chirivella (Автор), Olatz Etxaniz (Автор), Eva Fernández-Parra (Автор), Marta Guix (Автор), Carolina Hernández (Автор), Julio Lambea (Автор), Álvaro Montesa (Автор), Álvaro Pinto (Автор), Silverio Ros (Автор), Enrique Gallardo (Автор)
• Формат: ‌
• Опубликовано: BMC, 2018-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects are linked to clinical practice. Methods A non-exhaustive systematic re...